Brinkman, J.A., Hughes, S.H., Stone, P., Caffrey, A.S., Muderspach, L.I., Roman, L.D., Weber, J.S., and Kast, W.M. (2007). Therapeutic vaccination for HPV induced cervical cancers. Dis Markers 23, 337-352.

de Sanjose, S., Diaz, M., Castellsague, X., Clifford, G., Bruni, L., Munoz, N., and Bosch, F.X. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7, 453-459.

Garnett, G.P., Kim, J.J., French, K., and Goldie, S.J. (2006). Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 24 Suppl 3, S3/178-186.

Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A.C., Solomon, D., Bratti, M.C., Schiller, J.T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007). Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 298, 743-753.

Hung, C.F., Ma, B., Monie, A., Tsen, S.W., and Wu, T.C. (2008). Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin Biol Ther 8, 421-439.

Kanodia, S., Da Silva, D.M., and Kast, W.M. (2008). Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions. Int J Cancer 122, 247-259.